Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
60,841,273
-
Share change
-
+1,275,221
-
Total reported value
-
$256,209,479
-
Put/Call ratio
-
25%
-
Price per share
-
$4.21
-
Number of holders
-
117
-
Value change
-
+$3,687,790
-
Number of buys
-
69
-
Number of sells
-
40
Institutional Holders of BIODELIVERY SCIENCES INTL IN - COM (BDSI) as of Q3 2019
As of 30 Sep 2019,
BIODELIVERY SCIENCES INTL IN - COM (BDSI) was held by
117 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,841,273 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, BlackRock Inc., Nantahala Capital Management, LLC, Broadfin Capital, LLC, VANGUARD GROUP INC, Stonepine Capital Management, LLC, Rubric Capital Management LP, EMERALD ADVISERS, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., and EMERALD MUTUAL FUND ADVISERS TRUST.
This page lists
117
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.